Human Single-Nucleus RNA Sequencing Identifies CD47 as a Therapeutic Target for Doxorubicin-Induced Cardiomyopathy
- 9 September 2025
- journal article
- Published by Wolters Kluwer Health in Circulation
- Vol. 152 (10) , 661-681
Abstract
BACKGROUND: Doxorubicin cardiomyopathy (DoxCM) remains a significant clinical problem, but its underlying mechanisms remain incompletely understood. Identifying DoxCM mechanisms can lead to therapeutic interventions that improve patient outcomes. METHODS: We performed single-nucleus RNA sequencing on left ventricular myocardial tissue from patients with DoxCM versus nonischemic cardiomyopathy and nonfailing donors. This approach aimed to uncover the transcriptional changes associated with DoxCM. Additionally, we conducted immunostaining, flow cytometry, antibody neutralization, and cell depletion studies to validate our findings and define in vivo mechanisms. RESULTS: Compared with nonfailing donors and patients with nonischemic cardiomyopathy, left ventricular myocardium from patients with DoxCM exhibited increased POSTN (periostin) + activated fibroblasts, downregulation of genes involved in phagocytosis, and increased expression of the antiphagocytic molecule CD47. Immunostaining of human cardiac sections and murine studies demonstrated increased POSTN + cells and CD47 in DoxCM and in a murine breast cancer model. CD47 antibody neutralization both prevented and treated doxorubicin-induced reduction in left ventricular ejection fraction and fibrosis. Mechanistically, depletion of resident cardiac macrophages blocked the cardioprotective effects of CD47 neutralization and clearance of cardiac fibroblasts. CONCLUSIONS: Our data support CD47 as a disease-specific target and promising therapeutic approach for mitigating cardiac dysfunction in DoxCM.Keywords
This publication has 90 references indexed in Scilit:
- The antitumor activities of anti-CD47 antibodies require Fc-FcγR interactionsCancer Cell, 2023
- Sorting nexin 3 exacerbates doxorubicin-induced cardiomyopathy via regulation of TFRC-dependent ferroptosisActa Pharmaceutica Sinica B, 2023
- Generation and Functional Characterization of Monocytes and Macrophages Derived from Human Induced Pluripotent Stem CellsCurrent Protocols in Stem Cell Biology, 2020
- Phagocytosis by macrophages depends on histamine H2 receptor signaling and scavenger receptor 1Microbiologyopen, 2019
- Doxorubicin‐induced cardiotoxicity involves IFNγ‐mediated metabolic reprogramming in cardiomyocytesThe Journal of Pathology, 2018
- Combination of anthracyclines and anti-CD47 therapy inhibit invasive breast cancer growth while preventing cardiac toxicity by regulation of autophagyBreast Cancer Research and Treatment, 2018
- Anthracycline Chemotherapy and CardiotoxicityCardiovascular Drugs and Therapy, 2017
- Left Ventricular Mass in Patients With a Cardiomyopathy After Treatment With AnthracyclinesThe American Journal of Cardiology, 2012
- Interleukin-1 signaling mediates acute doxorubicin-induced cardiotoxicityBiomedicine & Pharmacotherapy, 2011
- CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem CellsCell, 2009